Ultralow doses of DEXTROMETHORPHAN (cas 125-71-3) protect mice from endotoxin-induced sepsis-like hepatotoxicity
-
Add time:09/08/2019 Source:sciencedirect.com
DEXTROMETHORPHAN (cas 125-71-3), a wildly used over-the-counter antitussive drug, is reported to have anti-inflammatory effects. Previously, we and others have demonstrated that dextromethorphan at micromolar doses displays potent hepatoprotective effects and enhances mice survival in a sepsis model. Moreover, we also observed potent anti-inflammatory and neuroprotective effects of subpicomolar concentrations of dextromethorphan in rodent primary neuron-glial cultures. The purpose of this study was to provide a proof of principle that ultralow dose dextromethorphan displays anti-inflammatory and cytoprotective effects in animal studies. Here, we report that subpico- and micromolar doses of dextromethorphan showed comparable efficacy in protecting mice from lipopolysaccharide/d-galactosamine (LPS/GalN)-induced hepatotoxicity and mortality. Mice were given injections of dextromethorphan from 30 min before and 2, 4 h after an injection of LPS/GalN (20 μg/600 mg/kg). Our results showed that dextromethorphan at subpicomolar doses promoted survival rate in LPS/GalN-injected mice. Ultralow dose dextromethorphan also significantly reduced serum alanine aminotransferase activity, TNF-α level and liver cell damage of endotoxemia mice. Mechanistic studies using primary liver Kupffer cell cultures revealed that subpicomolar concentrations of dextromethorphan reduced the NADPH oxidase-generated superoxide free radicals from Kupffer cells, which in turn reduced the elevation of its downstream reactive oxygen species (iROS) to relieve the oxidative stress and decreased TNF-α production in Kupffer cells. Taken together, these findings suggest a novel therapeutic concept of using ultralow doses of dextromethorphan for the intervention of sepsis or septic shock.
We also recommend Trading Suppliers and Manufacturers of DEXTROMETHORPHAN (cas 125-71-3). Pls Click Website Link as below: cas 125-71-3 suppliers
Prev:ReviewEnantioselective interactions of dextromethorphan and levomethorphan (cas 125-70-2) with the α3β4-nicotinic acetylcholine receptor: comparison of chromatographic and functional data
Next:Case ReportDeaths due to abuse of DEXTROMETHORPHAN (cas 125-71-3) sold over-the-counter in Pakistan) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationThe unexpected identification of the cannabimimetic, 5F-ADB, and DEXTROMETHORPHAN (cas 125-71-3) in commercially available cannabidiol e-liquids09/26/2019
- Research reportThe blockade of 5-HT1A receptors in the ventral tegmental area inhibited morphine/DEXTROMETHORPHAN (cas 125-71-3)-induced analgesia in pain rat models09/25/2019
- Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of DEXTROMETHORPHAN (cas 125-71-3) in hearing loss rat model09/24/2019
- Mutually augmenting interactions of DEXTROMETHORPHAN (cas 125-71-3) and sazetidine-A for reducing nicotine self-administration in rats09/10/2019
- Case ReportDeaths due to abuse of DEXTROMETHORPHAN (cas 125-71-3) sold over-the-counter in Pakistan09/09/2019
-
Health and Chemical more >